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A B S T R A C T
Introduction. Male-to-female (MtF) and female-to-male (FtM) individuals with transsexualism (International Clas-
siﬁcation of Diseases-10) may differ in core clinical and sociodemographic variables such as age, sexual orientation,
marriage and parenthood, school, educational level, and employment. Assessing and understanding the implication
of such differences may be a key to developing appropriate and effective treatment and intervention strategies for this
group. However, research in the area remains sparse and is often on small populations, making the generalization of
results from current studies on individuals diagnosed with transsexualism difﬁcult.
Aims. (i) To describe and assess key sociodemographic and treatment-related differences between MtF and FtM
individuals in a Danish population of individuals diagnosed with transsexualism; (ii) to assess possible implications of
such difference, if any, for clinical treatment initiatives for individuals diagnosed with transsexualism.
Methods. Follow-up of 108 individuals who had permission to undergo sex reassignment surgery (SRS, meaning
castration and genital plastic surgery) over a 30-year period from 1978 to 2008 through the Gender Identity Unit in
Copenhagen, Denmark. The individuals were identiﬁed through Social Security numbers. Clinical and sociodemo-
graphic data from medical records were collected.
Results. The sex ratio was 1.16:1 (MtF : FtM). Mean age at ﬁrst referral was 26.9 (standard deviation [SD] 8.8) years
for FtM and 30.2 (SD 9.7) for MtF individuals. Compared with MtF, FtM had a signiﬁcantly lower onset age (before
12 years of age) and lower age when permission for SRS was granted. Further, FtM individuals were signiﬁcantly
more often gynephilic (sexually attracted to females) during research period and less likely to start self-initiated
hormonal sex reassignment (SR) (treatment with cross-sex hormones). The MtF and FtM groups did not differ in
years of school, educational level, employment, or engagement in marriage and cohabitation.
Conclusions. As approximately half of MtF started cross-sex hormonal SR without attending a gender unit, future
treatment needs to focus on this group of MtF individuals in order to accommodate the medical risks of self-initiated
hormonal treatment.Earlier intervention with adolescents appears necessary since three-quarters of FtM individuals
before age 12 had problems with their assigned sex. For both MtF and FtM, we found problems in areas of school,
education, and employment and recommend further help in these core areas. Simonsen R, Hald GM, Giraldi A,
and Kristensen E. Sociodemographic study of danish individuals diagnosed with transsexualism. Sex Med
2015;3:109–117.
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Introduction
I n the World Health Organization classiﬁcationsystem, International Classiﬁcation of Diseases
(ICD)-10, transsexualism is categorized in the
group of “disorders of adult personality and behav-
ior,” speciﬁcally in the subgroup of “gender iden-
tity disorders” [1]. Central to the condition is that
an individual with normal somatic sexual differen-
tiation is unalterably convinced that she/he
belongs to the opposite sex [2,3].
According to the ICD-10, the following three
criteria must be met before an individual may be
diagnosed with transsexualism: (i) the person has
the desire to live and be accepted as a member of
the opposite sex; (ii) usually accompanied by a
sense of discomfort with or inappropriateness of
one’s anatomic sex; and (iii) a wish to have surgery
and/or hormonal treatment to make one’s body as
congruent as possible with one’s preferred sex [1].
The term “transsexualism” was used for the ﬁrst
time by Magnus Hirschfeld, a German doctor who
referred the ﬁrst Danish person for sex reassign-
ment surgery (SRS) in 1930. However, it was the
SRS in 1954 of U.S. soldier Christine Joergensen
at the University Hospital of Copenhagen,
Denmark, that delineated modern SRS using a
combination of hormones and surgery [4]. This
combination treatment prevails today.
Since the ﬁrst SRS, several follow-up studies of
individuals undergoing SRS have shown that the
combination of hormones and SRS is an effective
treatment and associated with many subsequent
positive life changes, such as reduction in gender
dysphoria and increased psychological well-being
[4–10].
Cross-cultural research on transsexualism sug-
gests country-speciﬁc variation in age at ﬁrst
requesting SRS as well as general differences in
sociodemographic characteristics of male-to-
female (MtF) vs. female-to-male (FtM) individu-
als. Studies from several European countries and
one from Singapore investigating the age of
requesting SRS show a variation between coun-
tries at what age the individuals are requesting SRS
as well as a difference between MtF and FtM indi-
viduals. Overall, the studies show that in MtF indi-
viduals, the request is between the age of 25 and 37
years [9,11–22], while the FtM individuals are
younger at their request, ranging from 20 to 30
years [11–13,23–25], for both groups with regional
differences. This may reﬂect the individual differ-
ences but also different practices and legal issues in
different countries.
In terms of marriage, relationships, and parent-
ing, research suggests that individuals diagnosed
with transsexualism at a group level have difﬁculties
in establishing and maintaining marriage and inti-
mate partnership [13,16,20,26,27]. Furthermore,
marriage and parenting are signiﬁcantly more
common among MtF individuals as compared with
FtM individuals. Having biological children ranges
from under 2% [28] to 10% [26] in FtM popula-
tions and from zero [29] to 57% [30] in MtF popu-
lations [22,31,32]. FtM individuals have been found
to more often live in a stable relationship with a
same-sex partner as comparedwithMtF individuals
[13,16,20,26,27]. Research on sexual orientation
has shown that FtM compared with MtF signiﬁ-
cantly more often report sexual attraction to same
assigned sex [11,12,18,20,22,24–26,28,30,33–35].
Regarding educational differences between the
FtM and MtF populations, studies indicate that
FtM individuals achieve a higher educational
level as compared with MtF individuals [18]. For
example, a Japanese study found that although
only 1.6% of the general population of Japan did
not attend school, 27% of FtM and 31% of MtF
individuals did not attend school [36].
Individuals with transsexualism in general hold
low employment status [16,20,28] and are often
socially marginalized [16,37,38] with MtF popula-
tions generally experiencing higher rates of unem-
ployment as compared with FtM individuals [16].
Critical limitations to existing research on
transsexualism include small sample sizes, use of
nonrepresentative transsexual samples, and/or
limitations to the array of variables investigated
[28,39,40]. In comparison, the cohort included in
the current study comprises almost all Danish
individuals with transsexualism who have received
permission to undergo SRS during a period of 30
years. They were all diagnosed by a trained psy-
chiatrist at the only Gender Identity Unit in
Denmark, Sexological Clinic, University Hospital
of Copenhagen (GIUUC). All participants had
following sessions with psychiatrist and trained
psychologist, psychological testing, and physical
examination.
Accordingly, the present study seeks to extend
current knowledge about characteristics of
transsexualism related to onset age of gender iden-
tity problems, referral age, age at permission to
undergo SRS, age at start of hormonal sex reas-
signment (SR), marriage, parenthood, sexual ori-
entation, school, education, and employment by
investigating differences between MtF and FtM
individuals included. Assessing and understanding
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the implication of such differences may be a key to
developing appropriate and effective treatment
and intervention strategies for this group.
Methods
Participants
The study is a follow-up study of the majority
(98%) of individuals in Denmark, diagnosed with
transsexualism, who in the period from 1978 to
2008 received permission from the Danish Health
and Medicines Authority to undergo SRS, and all
were included prior to SRS. Four of the 108 indi-
viduals did not make use of the permission to
undergo SRS. Individuals were referred to
GIUUC by GP, and all cost of the treatment were
paid by the Danish health care system. In
Denmark, all individuals with transsexualism who
want SRS are referred to the GIUUC for assess-
ment and clinical evaluation before they can apply
for permission to undergo SRS. A diagnose of
transsexualism is obligatory in order to be able to
get permission for SRS.
The sample comprised 58 MtF (assigned males)
and 50 FtM (assigned females) individuals. All par-
ticipants were diagnosed with transsexualism by a
psychiatrist according to ICD-8/ICD-10 criteria
[1].
Procedure
The study was approved by The Danish Data Pro-
tection Agency and the Danish Health and Medi-
cines Authority. Permission was obtained from
The Civil Law Board to identify names and Social
Security numbers of all individuals who had
received permission to undergo SRS from 1978 to
2008 and who were treated at the GIUUC.
Data on family background, education, employ-
ment, partnership, sexual orientation, biological
children, and process of SR were obtained from
medical records. Medical record data were
obtained based on interviews performed by a spe-
cialized psychiatrist, psychologist, and medical




Participants were divided into two groups. Group
1 consisted of participants who had sexual contacts
with partners of the same assigned sex. Group 2
consisted of participants who had sexual contacts
with partners of the opposite assigned sex or with
both opposite and same sex partners measured at
referral and when they received permission for
SRS [18,41].
Cohabitation
Cohabitation was measured at the time of permis-
sion to undergo SRS. Participants were divided
into two groups based on length of cohabitation,
with group 1 consisting of participants who had
lived with a partner for 6 or more months and
group 2 consisting of participants who lived with a
partner less than 6 months or not at all.
Marital Status
The two groups for this comparison were based on
ofﬁcial registration of marriage/same-sex partner-
ship at the time of referral. Group 1 consisted of
participants who were married, in a registered
partnership, or widowed/widowered, and group 2
consisted of participants who were not married/
same-sex partnership or who were divorced.
Biological Children
Participants were divided into two groups based
on self-reported information about being a bio-
logical parent or not (groups 1 and 2, respectively).
The data were collected at the time of permission
to undergo SRS.
Age of Onset of Transsexualism
Participants were divided into two groups based
on onset age of transsexualism. Group 1 consisted
of participants with self-reported information of
start of transsexualism before age 12, and group 2
consisted of participants with self-reported onset
age later than age 12 [11,17,25,42,43].
Self-Initiated Hormone Treatment
Participants were divided into two groups based
on how the participant self-reported prescription
of cross-sex hormones. Group 1 consisted of par-
ticipants who started treatment with cross-sex hor-
mones on the participant’s own initiative and not
prescribed by GIUUC. Group 2 consisted of par-
ticipants who started treatment with cross-sex hor-
mones prescribed by GIUUC after evaluation.
Years in School
The measure of years in school was dichotomized;
group 1 consisted of participants with 11 or fewer
years of education (primary school), and group 2
consisted of participants with 12 or 13 years of
education (high school) [44].
Further Education
Participants were divided into three groups based
on level of education after primary or secondary
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school. Group 1 consisted of participants with no
education. Group 2 consisted of participants who
had completed an apprenticeship or had up to 3
years of education. Group 3 consisted of partici-
pants who had 4 or more years of education [44].
Employment
For employment status, group 1 consisted of par-
ticipants with a paid job or who had student status.
Group 2 consisted of participants receiving sick-
ness or unemployment beneﬁts or who were
receiving social welfare or were pensioners.
Statistics
The statistical analyses were conducted in spss
version 19.0 (SPSS, IBM). The sociodemographic
and clinical variables were analyzed using descrip-
tive statistics. Means and standard deviations (SDs)
were calculated for continuous variables, and fre-
quencies and percentages were generated for
nominal and categorical variables. Differences
between the MtF and FtM populations were ana-
lyzed using the chi-squared (categorical data) or
Student’s t-test (continuous data).
Results
The mean age of the total sample at ﬁrst referral
was 28.7 years (SD 9.4; range 14–53). For MtF
individuals, the mean age at referral was 30.2 years
(SD 9.7) and for FtM individuals 26.9 years (SD
8.8). The participants had an average of 34 inter-
views (range 2–115) at GIUUC before they had
permission to undergo SRS. The average number
of years of evaluation and treatment from the ﬁrst
referral to permission to undergo SRS was 8.1
years for the MtF population and 5.9 years for the
FtM group.
Tables 1 and 2 shows the results for the vari-
ables related to study aim 1: onset age, age at ﬁrst
referral, age at permission to undergo SRS, self-
initiated cross-sex hormone treatment, sexual ori-
entation, marriage, cohabitation, and parenthood.
Signiﬁcant differences between MtF and FtM
were found in age at permission to undergo SRS,
with MtF individuals being signiﬁcantly older than
FtM individuals (P < 0.001) and the FtM group
being signiﬁcantly younger at the age of onset of
transsexualism than the MtF group (P < 0.001).
Self-initiated hormonal SR was signiﬁcantly more
common in MtF individuals than in FtM individu-
als, with twice as many MtF participants starting
cross-sex hormonal treatment on their own initia-
tive (P < 0.001). A signiﬁcant difference in sexual
orientation was found in the FtM individuals,
which more often were gynephilic (attracted to
females) both at the time of referral (P < 0.01) and
at the time of permission to undergo SRS
(P < 0.001). As seen from Table 2, MtF and FtM
individuals did not differ in number of years of
school, educational level, or employment status.
As the results may be inﬂuenced by changes of
clinical procedures and guidelines over time as
well as the cultural acceptance of transsexualism,
data were checked for systematic differences
between the ﬁrst 15 years (1978–1993) and the
next 15 years (1994–2008). No systematic differ-
ences were found.
Discussion
Using a unique sample of 98% of all Danish indi-
viduals who received permission to undergo SRS
from 1978 to 2008, we found a signiﬁcant differ-
ence in the FtM and MtF populations in terms of
age at permission for SRS, with FtM individuals
receiving permission on average 5 years earlier
than MtF individuals. This result is in line with a
majority of other previous studies, indicating that
FtM persons seek treatment earlier than MtF
[13,16,17,19–21,24].
We found a signiﬁcant difference in the self-
reported intake of cross-sex hormones, with twice
as many MtF as FtM individuals initiating cross-
sex hormonal SR on their own. This indicates that
although MtF individuals seek professional treat-
ment later, they are more inclined to start hor-
monal SR before consulting a gender unit as
compared with FtM. This outcome likely explains
why we found no difference in age when starting
hormonal SR and suggests that the actual age
when starting transformation to the opposite sex is
similar for the MtF and FtM populations. As dis-
cussed by Gomez-Gil et al. [28] and Fischer et al.
[32], the reason why MtF individuals start cross-
sex hormone treatment on their own initiative may
be that some MtF individuals have experienced
difﬁculties, in some cases discrimination and
stigma [45,46], in seeking medical help from
gender units, but nonetheless felt intense discom-
fort with their assigned sex motivating them to
start hormonal treatment on their own initiative.
In this regard, data showed that the majority of
self-initiated treatment with cross-sex hormones
was prescribed by a GP or a private gynecologist.
Signiﬁcantly more FtM than MtF participants
had a sexual attraction to individuals of their
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assigned sex. We found that the number of both
MtF and FtM participants reporting sexual attrac-
tion to individuals of their assigned sex increased
from the time of ﬁrst referral to the time of permis-
sion to undergo SRS. This ﬁnding corresponds
with previous studies indicating that theMtF popu-
lation may be more heterogeneous than the FtM
population and the MtF individuals having a sig-
niﬁcant gynephilic orientation [10,12,18,20,22,24–
26,28,30,33–35]. In this regard, we found that 60%
of the MtF population was gynephilic, a relatively
high number compared with other research, which
may be attributed to the fact that we measured
sexual orientation based on sexual behavior and not
on sexual fantasies [18,41]. We found an increase in
reported sexual attraction to individuals of their
same assigned sex in both groups during treatment
at GIUUC, indicating that sexual orientation may
change over time as noted by Lawrence [31]. This
change is perhaps because of hormones, ﬂexibility
in sexual orientation caused by gender transitioning
as noted by Daskalos [47], an effort to give socially
desirable answers, and/or an overestimation by
MtF individuals of androphilic attraction as indi-
cated in studies from Italian and Spanish studies
[28,32]. In this connection, it is important to
acknowledge research suggesting that it may not be
unusual for gynephilic MtF individuals to present
themselves as being androphilic [32] to enhance
their chances of SRS as suggested by Gomez-Gil et
al. [28].
The sex ratio in our sample was 1.16:1
(MtF : FtM). This ratio is in line with recent ﬁnd-
ings from Norway [37] and Sweden [19,48] but in
contrast to ﬁndings from Belgium [16,18], the
Netherlands [12,49], Germany [19], and Spain
Table 1 Baseline demographics/sexual orientation/cross-sex hormones/parenthood for MtF and FtM individuals, n (%)
MtF (n = 58) FtM (n = 50)
Mean age at referral, years (SD) 30.2 (9.7) 26.9 (8.8)
Mean age at permission for SRS, years (SD) 37.4 (9.6) 32.6 (8.0)**
Mean age at initiating hormonal SR, years (SD) 32.0 (9.8) 29.9 (8.3)
Number of sessions at gender unit, n (%)
1–30 30 (51.7) 23 (46.0)
31–60 21 (36.2) 23 (46.0)
>60 5 (8.6) 2 (4.0)
Unknown 2 (3.4) 2 (4.0)
Marriage, at referral, n (%)
Yes 9 (15.5) 3 (6.0)
Widow 0 1 (2.0)
No 41 (70.7) 41 (82.0)
Divorced 8 (13.8) 5 (10.0)
Cohabitation >6 months, at permission for SRS, n (%)
Yes 31 (53.4) 35 (70.0)
No 27 (46.6) 15 (30.0)
Attracted to one’s own assigned sex orientation at referral, n (%)
Yes 22 (37.9) 29 (58.0)*
No 35 (60.3) 21 (42.0)
Unknown 1 (1.7) 0
Attracted to one’s own assigned sex at permission for SRS, n (%)
Yes 26 (44.8) 43 (86.0)**
No 31 (53.4) 7 (14.0)
Unknown 1 (1.7) 0
Biological children at permission for SRS, n (%)
Yes 13 (22.4) 5 (10.0)
No 45 (77.6) 44 (88.0)
Unknown 0 1 (2.0)
Onset age, n (%)
Onset age < age 12 24 (41.4) 38 (76.0)**
Onset age > age 12 33 (56.9) 11 (22.0)
Unknown 1 (1.7) 1 (2.0)
Self-initiated hormone treatment, n (%)
Yes 32 (55.2) 12 (24.0)**
Prescribed by GP/gynecologist 23 (39.7) 10 (20.0)
Brought via the Internet 2 (3.4) 1 (2.0)
Acquired through friends/family 7 (12.1) 1 (2.0)
No 22 (37.9) 37 (74.0)
Unknown 4 (6.9) 1 (2.0)
*P < 0.01; **P < 0.001.
FtM = female-to-male; MtF = male-to-female; SRS = sex reassignment surgery.
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[17,28] where, in general, the sex ratio of MtF to
FtM is three to one (3:1). Also, for comparison, in
the only larger scaleDanish study [35] from1982 of
37 individuals with permission to undergo SRS, the
sex ratio of MtF vs. FtM was 3.6:1. This indicates
that over time, there has been a change in the ratio
of individuals who had permission to undergo SRS
with an increase in the number of assigned FtM in
Denmark, and future studies will show if the same
trend will appear in other countries. We have no
reason to believe that there has been an accumula-
tion of MtF cases in recent years and that this
predominance has only recently been reduced.Due
to the heterogeneity of the MtF individuals, one
could speculate if there has been a restraint in
permission to undergo SRS for MtF individuals.
These MtF individuals may have been led into
private treatment abroad [50]. The present study
may also indicate that when it comes to permission
to undergo SRS, the sexes are equal, which is in line
with a the study by Landen et al. on a Swedish
population [48]. Thus, gender differences in sex
ratio in initial phases of treatment found in other
studies may be attributed to heterogeneity in the
MtF group [25,41,51,52].
Overall, about 50% of our study group had no
education further than primary and secondary
school. We do not have a control group, but in
the Danish population 15–69 years of age, the
percentage of individuals with no education
beyond primary and secondary school was about
34% in 2003 [53]. Previous studies [18,26,54]
suggest that FtM individuals on average are
better educated than MtF individuals. No such
difference was found in the current study.
Accordingly, we do not know if the MtF indi-
viduals in our study were better educated than in
other studies or if the FtM individuals were less
well educated than in other studies. We encour-
age future research to explore this potential dis-
crepancy in research ﬁndings.
Individuals on social welfare and pensioners,
and the unemployment rate (16–19%) in our study
group were equally high in FtM and MtF individu-
als and were elevated compared with the Danish
population in general, in which the unemployment
rate in the period 1978–2008 ranged from 4% to
7% [55,56]. This elevated unemployment rate may
be caused by lack of schooling and education level,
and/or, as it has been found in other studies
[28,32,38], because of the marginalization and
social exclusion that these persons may suffer
[28,32,38]. The employment rates for the popula-
tion in the present study (54–62%) were lower
than the employment rates found in Italian [32]
(76%) and Spanish (83%) [28] samples of individu-
Table 2 Sociodemographics by MtF and FtM, n (%)
MtF (n = 58) FtM (n = 50)
Years of primary and secondary education
≤11 40 (69.0) 38 (76.0)
12–13 (completion of high school) 16 (27.6) 12 (24.0)
Missing information 2 (3.4) 0
Further education beyond primary and secondary school at time of referral
None 29 (50.0) 30 (60.0)
≤3 or having received an apprenticeship 21 (36.2) 8 (16.0)
4 years or more 5 (8.6) 10 (20.0)
Unknown 3 (5.2) 2 (4.0)
Further education beyond primary and secondary school at the time when
permission for SRS was granted
None 25 (43.1) 25 (50.0)
≤3 or having received an apprenticeship 21 (36.2) 13 (26.0)
4 years or more 8 (13.8) 10 (20.0)
Unknown 4 (6.9) 2 (4.0)
Employment at time of referral
Employment 36 (62.1) 31 (62.0)
Unemployment
Sickness or unemployment benefits 12 (20.7) 7 (14.0)
Social welfare/pensioners 10 (17.3) 12 (24.0)
Employment at the time when permission for SRS was granted
Employment 32 (55.2) 27 (54.0)
Unemployment
Sickness or unemployment benefits 5 (8.6) 11 (22.0)
Social welfare/pensioners 20 (34.5) 11 (22.0)
Unknown 1 (1.7) 1 (2.0)
FtM = female-to-male; MtF = male-to-female; SRS = sex reassignment surgery.
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als with transsexualism but comparable with the
MtF populations in Belgium (55%) [18] and
Sweden (63–70%) [20].
The present rates of unemployment/social
welfare/pensioners were high compared with
other studies, which may indicate that the Danish
welfare system is more supportive than systems in
some other European countries, given the lack
of evidence suggesting that individuals with
transsexualism are more discriminated against in
Denmark than in other countries [32,38]. During
treatment for transsexualism, we saw an increase in
early retirees that was not the result of age because
the maximum age for participants in our study who
had permission to undergo SRS was 56 years and
the mean age for retirement in Denmark is 61.3
years. Additionally, unemployment rates increased,
indicating that these persons’ working ability
decreased during treatment. The present study
cannot explain these changes.
Contrary to previous studies [14,18,20,22,31]
indicating that more MtF individuals had been
engaged in marriage and parenthood, we found no
signiﬁcant difference in marriage or parenthood in
the two groups. However, this may very likely be
the result of low statistical power in our sample
arising from the fact that very few individuals in our
group in fact had been married (i.e., nine MtF vs.
three FtM individuals). Alternatively, it may be that
individuals diagnosed with transsexualism and
approved for SRS during the investigated time
period represent a selected group of individuals
with transsexualism in which marriage and parent-
hood are relatively uncommon as seen in a study
from Singapore [57].
The length of treatment for MtF and FtM (8.1
and 5.9 years, respectively) cannot be explained by
the present study but may reﬂect different evalua-
tion and clinical procedures over time. Conceptu-
alization, evaluation, and treatment of individuals
with GID have undergone substantial changes
over the last 30 years, and the current scheduled
length of treatment is aimed at being 1.5–2 years
to permission for SRS moving more toward a
“informed consent model.” Another explanation
may be that some individuals had several referrals
to GIUUC before having permission for SRS, and
the length of treatment was calculated from their
ﬁrst contact with the clinic.
The strength of this study lies in the unique
cohort included. Thus, on a national basis and over
a 30-year period, 98% of all individuals with
transsexualism approved for SRS were included in
this study. This gives unique insights into the
sociodemographic nature of this sample, core
aspects of information related to treatment, and a
unique position to assess differences between MtF
and FtM on these variables.
The study does have some limitations. First,
several of the items assessed were based on self-
report and therefore perhaps not accurate [32].
Second, although we had a very large cohort for
this type of study, still, some of our statistics and
especially comparisons between MtF and FtM
may suffer from low statistical power, thus increas-
ing the changes for type II errors. Third, we are
unsure how/if the results may generalize to indi-
viduals with transsexualism not attending a public
clinic specializing in gender identity disorders.
Despite these limitations, the present study
reports the sociodemographic and clinical charac-
teristics of a unique cohort of 108 Danish individu-
als with transsexualism. It provides different
proﬁles for the MtF and FtM populations and
suggests differences in age at onset and permission
to undergo SRS, sexual orientation toward own
assigned sex, and self-initiated hormonal SRS. This
information is important for facilitating attention
to and understanding and choice of appropriate
treatments and interventions for individuals diag-
nosed with transsexualism. Providing easier access
for MtF individuals to receive cross-sex hormonal
SR could avoid intake of cross-sex hormones before
psychiatric and psychological evaluation at
GIUUC and the possible resulting dangerous and
negative side effects. Our research reveals that
76.0% of FtM and 41.4% of MtF individuals who
later had permission to undergo SRS had an onset
age of transsexualism before 12 years, indicating a
need for advisory and treatment facilities for chil-
dren and adolescents. The average time of treat-
ment fromﬁrst referral to permission for SRSwas 7
years, which seems a long time period compared
with recommendations from the World Profes-
sional Association for Transgender Health [3] but
does not reﬂect the practice at the GIUUC today.
Issues related to school, education, and employ-
ment status may require attention by political
and/or health personnel in order to provide
adequate help and possibilities to alleviate prob-
lems related to these core areas of life.
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